NCT01039662已完成不适用
Effects of the Combination of L-Arabinose and Indigestible Dextrin on Glycemic Index: a Double-Blind, Crossover Trial
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 19
- 试验地点
- 1
- 主要终点
- Postprandial glucose level
研究概览
简要总结
This study aims to investigate the effect of supplement containing L-arabinose and indigestible dextrin on dietary glycemic index.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Prevention
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 20 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy as based on medical history and physical examination
- •BMI is less or equal to 30 kg/m2
- •Willing not to serve as blood donor during the study
- •Informed consent signed
排除标准
- •Impaired Glucose Tolerance
- •Female subjects who are pregnant or nursing a child
- •Participation in any clinical trial up to 90 days before Day 1 of this study
- •Renal or hepatic dysfunction
- •Heart disease
- •Under medication
研究组 & 干预措施
Oolong tea containing L-arabinose and indigestible dextrin
Experimental
干预措施: L-arabinose and indigestible dextrin (Dietary Supplement)
Oolong tea
Placebo Comparator
干预措施: Placebo (Dietary Supplement)
结局指标
主要结局
Postprandial glucose level
时间窗: 2 hours
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Effects of the Combination of L-Arabinose and Indigestible Dextrin on ObesityObesityNCT00880646Hiroshima University70
已完成
不适用
The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in ManInsulin ResistanceNCT01957098University of Copenhagen14
已完成
1 期
The Effects of L-arabinose on Intestinal Sucrase Activity in ManBlood GlucoseNCT00302302University of Copenhagen15
招募中
不适用
‘The effect of L-arabinose on the glycaemic and insulinemic responses after consumption of a liquid product’Eating behaviour, Obesity, Diabetes Mellitus, Metabolic healthNL-OMON22940Wageningen University (WUR)24
已完成
不适用
The effect of L-arabinose on the glycaemic and insulinemic response after consumption of a liquid product.Diabetes type 2metabolic diseases10018424NL-OMON45701Wageningen Universiteit24